US Patent Issued to JANSSEN BIOTECH on March 24 for "Subcutaneous formulations of anti-CD38 antibodies and their uses" (Pennsylvania Inventors)

ALEXANDRIA, Va., March 24 -- United States Patent no. 12,583,936, issued on March 24, was assigned to JANSSEN BIOTECH INC. (Horsham, Pa.).

"Subcutaneous formulations of anti-CD38 antibodies and their uses" was invented by Richard Jansson (Spring House, Pa.) and Vineet Kumar (Spring House, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to subcutaneous formulations of anti-CD38 antibodies and their uses."

The patent was filed on May 5, 2025, under Application No. 19/198,946.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=...